Engineering analysis of multienzyme cascade reactions for 3'-sialyllactose synthesis.

3ʹ-sialyllactose CMP-N-acetyl- d-neuraminic acid N-acetyl- d-mannosamine N-acetyl- d-neuraminic acid (Neu5Ac) biocatalysis lactose lyase multienzyme cascade reaction sialo-oligosaccharides synthase α2,3-sialyltransferase

Journal

Biotechnology and bioengineering
ISSN: 1097-0290
Titre abrégé: Biotechnol Bioeng
Pays: United States
ID NLM: 7502021

Informations de publication

Date de publication:
11 2021
Historique:
revised: 29 06 2021
received: 20 05 2021
accepted: 18 07 2021
pubmed: 22 7 2021
medline: 4 3 2022
entrez: 21 7 2021
Statut: ppublish

Résumé

Sialo-oligosaccharides are important products of emerging biotechnology for complex carbohydrates as nutritional ingredients. Cascade bio-catalysis is central to the development of sialo-oligosaccharide production systems, based on isolated enzymes or whole cells. Multienzyme transformations have been established for sialo-oligosaccharide synthesis from expedient substrates, but systematic engineering analysis for the optimization of such transformations is lacking. Here, we show a mathematical modeling-guided approach to 3'-sialyllactose (3SL) synthesis from N-acetyl- d-neuraminic acid (Neu5Ac) and lactose in the presence of cytidine 5'-triphosphate, via the reactions of cytidine 5'-monophosphate-Neu5Ac synthetase and α2,3-sialyltransferase. The Neu5Ac was synthesized in situ from N-acetyl- d-mannosamine using the reversible reaction with pyruvate by Neu5Ac lyase or the effectively irreversible reaction with phosphoenolpyruvate by Neu5Ac synthase. We show through comprehensive time-course study by experiment and modeling that, due to kinetic rather than thermodynamic advantages of the synthase reaction, the 3SL yield was increased (up to 75%; 10.4 g/L) and the initial productivity doubled (15 g/L/h), compared with synthesis based on the lyase reaction. We further show model-based optimization to minimize the total loading of protein (saving: up to 43%) while maintaining a suitable ratio of the individual enzyme activities to achieve 3SL target yield (61%-75%; 7-10 g/L) and overall productivity (3-5 g/L/h). Collectively, our results reveal the principal factors of enzyme cascade efficiency for 3SL synthesis and highlight the important role of engineering analysis to make multienzyme-catalyzed transformations fit for oligosaccharide production.

Identifiants

pubmed: 34289079
doi: 10.1002/bit.27898
pmc: PMC9290085
doi:

Substances chimiques

3'-sialyllactose 0
Oligosaccharides 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4290-4304

Informations de copyright

© 2021 The Authors. Biotechnology and Bioengineering Published by Wiley Periodicals LLC.

Références

Biotechnol Adv. 2008 Sep-Oct;26(5):436-56
pubmed: 18565714
Carbohydr Res. 2019 Jan 15;472:86-97
pubmed: 30529493
Glycobiology. 2013 Nov;23(11):1293-304
pubmed: 23969291
Org Lett. 2006 May 25;8(11):2393-6
pubmed: 16706534
Enzyme Microb Technol. 2016 Jun;87-88:70-8
pubmed: 27178797
Appl Microbiol Biotechnol. 2008 Oct;80(5):757-65
pubmed: 18716769
Chemistry. 2017 Oct 26;23(60):15143-15149
pubmed: 28833646
J Biol Chem. 2005 Feb 4;280(5):3555-63
pubmed: 15516336
J Biotechnol. 2008 Apr 30;134(3-4):261-5
pubmed: 18378033
Chem Commun (Camb). 2015 Feb 21;51(15):3083-6
pubmed: 25619424
Biotechnol Bioeng. 2021 Nov;118(11):4290-4304
pubmed: 34289079
Adv Carbohydr Chem Biochem. 2015;72:113-90
pubmed: 26613816
Biotechnol Bioeng. 2019 Sep;116(9):2146-2155
pubmed: 31062868
Org Biomol Chem. 2011 Apr 21;9(8):2784-9
pubmed: 21359399
Sci Rep. 2011;1:142
pubmed: 22355659
Curr Opin Chem Biol. 2021 Apr;61:81-95
pubmed: 33310623
Biochem Biophys Res Commun. 2005 Dec 23;338(3):1507-14
pubmed: 16274664
Bioorg Med Chem Lett. 2011 Sep 1;21(17):5037-40
pubmed: 21592790
Glycobiology. 2016 Apr;26(4):353-9
pubmed: 26582604
ACS Synth Biol. 2021 May 21;10(5):923-938
pubmed: 33909411
J Org Chem. 2016 Nov 18;81(22):10809-10824
pubmed: 27736072
Org Biomol Chem. 2016 Mar 14;14(10):2809-18
pubmed: 26881499
N Biotechnol. 2015 Dec 25;32(6):658-64
pubmed: 25534674
Appl Microbiol Biotechnol. 2013 Jun;97(11):4775-84
pubmed: 23420269
Carbohydr Res. 2017 Nov 8;451:51-58
pubmed: 28961426
Biotechnol Adv. 2019 Nov 15;37(7):107406
pubmed: 31200016
Chembiochem. 2017 Aug 4;18(15):1544-1550
pubmed: 28474804
Biotechnol Bioeng. 1999;66(2):131-6
pubmed: 10567071
Curr Opin Biotechnol. 2019 Apr;56:130-137
pubmed: 30502637
Biotechnol Adv. 2019 Sep - Oct;37(5):667-697
pubmed: 30935964
J Biotechnol. 2017 Sep 20;258:79-91
pubmed: 28764968
Int J Mol Sci. 2019 Oct 23;20(21):
pubmed: 31652818
Carbohydr Res. 2019 Jan 15;472:115-121
pubmed: 30562693
Appl Environ Microbiol. 2011 Apr;77(7):2471-8
pubmed: 21317263
Microb Biotechnol. 2016 Sep;9(5):601-9
pubmed: 27418373
Bioresour Technol. 2012 Jul;115:183-95
pubmed: 22531164
Bioorg Med Chem. 2013 Aug 15;21(16):4778-85
pubmed: 23535562
Nucleic Acids Res. 2012 Jan;40(Database issue):D770-5
pubmed: 22064852
Eur J Biochem. 1984 Apr 2;140(1):203-8
pubmed: 6705794
J Biotechnol. 2020 Oct 10;322:54-65
pubmed: 32653637
Nat Protoc. 2006;1(5):2485-92
pubmed: 17406495
J Biotechnol. 2018 Oct 10;283:120-129
pubmed: 30044949
Microb Cell Fact. 2015 Dec 09;14:197
pubmed: 26655367
Carbohydr Res. 1998 Feb;306(4):575-8
pubmed: 9679278
Biotechnol Adv. 2020 Nov 15;44:107613
pubmed: 32822768
FEBS Lett. 2014 Aug 25;588(17):2978-84
pubmed: 24945729
J Biosci Bioeng. 2021 Mar;131(3):271-276
pubmed: 33168471
Enzyme Microb Technol. 1997 Apr;20(5):393-400
pubmed: 9084208
J Am Chem Soc. 2009 Dec 30;131(51):18467-77
pubmed: 19947630
Biotechnol Bioeng. 2018 Jan;115(1):192-205
pubmed: 28922469
Carbohydr Res. 2010 Jul 2;345(10):1394-9
pubmed: 20231015
Nutr Rev. 2016 Oct;74(10):635-44
pubmed: 27634978
Appl Microbiol Biotechnol. 2007 Sep;76(3):597-605
pubmed: 17604986
FEBS J. 2009 Jan;276(2):410-24
pubmed: 19137631

Auteurs

Sabine Schelch (S)

Austrian Centre of Industrial Biotechnology, Graz, Austria.
Institute of Biotechnology and Biochemical Engineering, Graz University of Technology, NAWI Graz, Graz, Austria.

Manuel Eibinger (M)

Institute of Biotechnology and Biochemical Engineering, Graz University of Technology, NAWI Graz, Graz, Austria.

Stefanie Gross Belduma (S)

Institute of Biotechnology and Biochemical Engineering, Graz University of Technology, NAWI Graz, Graz, Austria.

Barbara Petschacher (B)

Austrian Centre of Industrial Biotechnology, Graz, Austria.
Institute of Biotechnology and Biochemical Engineering, Graz University of Technology, NAWI Graz, Graz, Austria.

Jürgen Kuballa (J)

GALAB Laboratories GmbH, Hamburg, Germany.

Bernd Nidetzky (B)

Austrian Centre of Industrial Biotechnology, Graz, Austria.
Institute of Biotechnology and Biochemical Engineering, Graz University of Technology, NAWI Graz, Graz, Austria.

Articles similaires

High-throughput Bronchus-on-a-Chip system for modeling the human bronchus.

Akina Mori, Marjolein Vermeer, Lenie J van den Broek et al.
1.00
Humans Bronchi Lab-On-A-Chip Devices Epithelial Cells Goblet Cells
Female Biofilms Animals Lactobacillus Mice
Saccharomyces cerevisiae Aldehydes Biotransformation Flavoring Agents Lipoxygenase
1.00
Algorithms Computer Simulation Models, Biological Programming Languages Humans

Classifications MeSH